Filing Flows › National Healthcare Properties (NHP) › Guidance & outlook
National Healthcare Properties (NHP) guidance and outlook
National Healthcare Properties (NHP) raised its guidance on Nov 4, 2026: Stock-based compensation $27.0M–$28.0M for FY2026; Capital expenditures $22.0M–$25.0M for FY2026. National Healthcare Properties' 10-Q filed Nov 6, 2026 makes 10 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Stock-based compensation | FY2026 | $27.0M–$28.0M | raised |
| Capital expenditures | FY2026 | $22.0M–$25.0M | reaffirmed |
From the earnings release filed Nov 4, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 6, 2026
- Because of our TRSs’ recent operating history of losses and the adverse economic impacts from increases in the rate of inflation in recent years on the results of operations of our SHOP communities, we are not able to conclude that it is more likely than not we will realize the future benefit of our deferred tax assets; thus we have recorded a 100% valuation allowance on our net deferred tax assets through…
- If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our consolidated statements of comprehensive loss.
- We closely monitor our current and anticipated liquidity position relative to our current and anticipated demands for cash and believe that we have sufficient current liquidity to meet our financial obligations for at least the next 12 months.
- We expect to fund our future short-term operating liquidity requirements, including acquisitions and distributions to holders of common stock, through a combination of current cash on hand, net cash provided by our operating activities and property dispositions, future draws under our Revolving Facility, issuance of equity securities and potential new financings utilizing certain of our unencumbered properties.
- We anticipate our rate of capital expenditure for the OMF and SHOP segments during the remainder of 2026 to be relatively consistent with the nine months ended September 30, 2026, excluding capital expenditures related to newly acquired communities and redevelopments or savings resulting from the sale of properties.
- There can be no assurance that we will complete acquisitions on a timely basis or on acceptable terms and conditions, if at all.
- Our ability to improve operations at our existing properties is also subject to a variety of risks and uncertainties, many of which are beyond our control, and there can be no assurance we will be successful in achieving this objective.
- As a result, our operating results imply that the value of our real estate investments will decrease predictably over a set time period.
- However, we believe that the value of our real estate investments will fluctuate over time based on various market conditions and as such, depreciation under historical cost accounting may be less informative.
- As inflation rates increase or persist at high levels, the cost of providing medical care at our SHOP communities, particularly labor costs, will increase.
National Healthcare Properties' latest quarter
National Healthcare Properties, Q3 2026: revenue $103M (+20% year over year), operating margin 30.9%, net earnings $17.8M, operating cash flow $15.7M. The chart follows the revenue to costs, profit and cash.
Questions
Did National Healthcare Properties raise or lower its guidance?
National Healthcare Properties (NHP) raised its guidance on Nov 4, 2026: Stock-based compensation $27.0M–$28.0M for FY2026; Capital expenditures $22.0M–$25.0M for FY2026.
What does National Healthcare Properties expect?
Because of our TRSs’ recent operating history of losses and the adverse economic impacts from increases in the rate of inflation in recent years on the results of operations of our SHOP communities, we are not able to conclude that it is more likely than not we will realize the future benefit of our deferred tax assets; thus we have recorded a 100% valuation allowance on our net deferred tax assets through… If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our consolidated statemen
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.